| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3dbadf11b8d5bc921d1dcb847c3a3ef2 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 |
| filingDate |
2016-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79217594a4983d7091ddf02dd1353720
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e72839d06ab5d305dca8e524f1b2ef13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acfac94531ad7211e7e565d9cd8f7996 |
| publicationDate |
2017-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2017068363-A1 |
| titleOfInvention |
New use of pemirolast |
| abstract |
According to the invention there is provided pemirolast, or a pharmaceutically acceptable salt thereof, for use in the treatment of airway hyperresponsiveness. Suitable lower doses of pemirolast are least about 110 mg per day. |
| priorityDate |
2015-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |